Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer - For More Information Visit For More Information Visit tinyurl.com/yc742vkp #ESMO #Vulvar_Cancer #Corcept_Therapeutics #Rare_Cancers
Rare Diseases
@CheckOrphan
CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs
5.3K Following 18K Followers 30K Posts
Latest posts 5
Neurizon Announces First Participant Completes 36-Week Phase of HEALEY ALS Trial and Transitions to Active Treatment Extension - For More Information Visit tinyurl.com/47j4evmm @Neurizon_ltd #Rare_Diseases #ALS #Orphan_Drugs #Amyotrophic_Lateral_Sclerosis
Lexeo Therapeutics Reports Positive Interim Phase I/II Data for LX2020, Demonstrating Reduced Arrhythmia Burden in PKP2-ACM Patients - For More Information Visit tinyurl.com/5faf6v69 #Lexeo_Therapeutics #ACM #Arrhythmogenic_Cardiomyopathy #Rare_Diseases #Orphan_Drugs
Roche’s Gazyva/Gazyvaro Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy - For More Information Visit tinyurl.com/4n77jcsh @Roche #Rare_Diseases #Orphan_Drugs #pMN #FDA #Primary_Membranous_Nephropathy #kidney_Diseases #Gazyva
Novartis Receives Positive CHMP Opinion for Cosentyx® in Adolescents aged 12+ with Hidradenitis Suppurativa (HS) - For More Information Visit tinyurl.com/4p5twcjc @Novartis #CHMP #Rare_Diseases #Orphan_Drugs #Cosentyx #Hidradenitis_Suppurativa #Drug_Research